Dr. Lal PathLabs Receives Favorable Appellate Order Regarding ESOP Expenses
Dr. Lal PathLabs Limited has received a favorable appellate order from the Income Tax Department regarding an assessment order issued on March 31, 2024. The decision follows an appeal filed by the company against the original assessment.On July 17, 2026, the company received the appellate order dated July 16, 2026, from the Commissioner of Income Tax (Appeals). The authority has allowed the company's appeal and decided the matter in its favor.
The favorable ruling pertains to the deduction claimed on account of Employee Stock Option Plan (ESOP) expenses. The appellate order confirms that a deduction of INR 32,66,18,927 is allowed for the company.
The details of the appellate order are summarized in the table below:
| Particulars | Details |
|---|---|
| Name of the authority | Commissioner of Income Tax (Appeals), Income Tax Department |
| Nature and details of the action(s) taken, initiated or order(s) passed | Appellate Order under section 250 of the Income Tax Act, 1961 from Commissioner of Income Tax (Appeals), Income Tax Department |
| Date of receipt of direction or order | July 17, 2026 (03:03 AM - IST) |
| Details of the violation(s)/ contravention(s) committed or alleged to be committed | Upon filing of an appeal against assessment order dated March 31, 2024, the Company has received an appellate order dated July 16, 2026 from Income Tax Department, whereby our appeal is allowed and decided in Company's favor and accordingly deduction claimed on account of ESOP Expenses of INR 32,66,18,927/- has been allowed. |
| Impact on financial, operation or other activities of the listed entity | Not Applicable, since appeal has been favor of the Company |
CENTRUM Stock Price Movement
Shares of Centrum Capital Limited on Friday slipped by 2.00% to settle at ₹24.07. The stock saw a total turnover of 196,425 shares as it retreated from the previous day's close.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.